In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.

President Donald Trump has locked in a sweeping set of pricing agreements with nine of the world's biggest drugmakers, ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

President Donald Trump and nine major pharmaceutical companies announced agreements to lower the cost of medications for cash ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

Cost audit applies to pharma companies crossing prescribed turnover limits, ensuring transparency and compliance with price controls under the ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

New Jersey-based pharma companies joined White House drug pricing deals aimed at lowering prescription drug costs under Trump’s policy.

Brand-name drugs unlikely to see price increases from tariffs, drugmakers expected to absorb initial costs Tariff costs could threaten access to cheap generic drugs, which have thin profit margins ...

The expansion announcements come at a time when President Donald Trump has threatened massive tariffs on pharmaceutical imports to the U.S. Others say it's not certain if these plans — by Bristol ...

Philadelphia sues Pharmacy Benefit Managers and insulin manufacturers for allegedly colluding to inflate insulin prices, ...